CLINICAL_TRIALS
trial_result
· 2007-05-10
Clinical Trial Update: Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes [Phase 4]
Summary
Phase 4 trial reports that simvastatin lowers circulating osteoprotegerin levels in patients with type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Aarhus | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED